Abbvie Inc ABBV:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:34 PM EST
147.40UNCH (UNCH)
Volume
216,246
Close
147.40quote price arrow down-0.39 (-0.26%)
Volume
4,353,730
52 week range
132.83 - 175.91
Loading...
  • Open147.92
  • Day High148.70
  • Day Low147.11
  • Prev Close147.79
  • 52 Week High175.91
  • 52 Week High Date04/08/22
  • 52 Week Low132.83
  • 52 Week Low Date01/26/22

Key Stats

  • Market Cap260.674B
  • Shares Out1.77B
  • 10 Day Average Volume6.86M
  • Dividend5.92
  • Dividend Yield4.02%
  • Beta0.60
  • YTD % Change-8.79

KEY STATS

  • Open147.92
  • Day High148.70
  • Day Low147.11
  • Prev Close147.79
  • 52 Week High175.91
  • 52 Week High Date04/08/22
  • 52 Week Low132.83
  • 52 Week Low Date01/26/22
  • Market Cap260.674B
  • Shares Out1.77B
  • 10 Day Average Volume6.86M
  • Dividend5.92
  • Dividend Yield4.02%
  • Beta0.60
  • YTD % Change-8.79

RATIOS/PROFITABILITY

  • EPS (TTM)7.51
  • P/E (TTM)19.64
  • Fwd P/E (NTM)11.78
  • EBITDA (TTM)28.23B
  • ROE (TTM)90.32%
  • Revenue (TTM)57.819B
  • Gross Margin (TTM)71.16%
  • Net Margin (TTM)23.21%
  • Debt To Equity (MRQ)435.20%

EVENTS

  • Earnings Date02/09/2023
  • Ex Div Date01/12/2023
  • Div Amount1.48
  • Split Date-
  • Split Factor-

Related Video

January Monthly Meeting: Cramer shares his outlook for 2023 and why he's more optimistic than most
VIDEO56:3256:32
CNBC Investing ClubJanuary Monthly Meeting: Cramer shares 2023 outlook and why he's more optimistic

Profile

MORE
AbbVie Inc. is a research-based biopharmaceutical company, which is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta; aesthetics products that include Botox Cosmetic, Juvederm Collection and others; neuroscience products, such as Botox...
Richard Gonzalez
Chairman of the Board, Chief Executive Officer
Robert Michael CPA
President, Vice Chairman of the Board
Scott Reents
Chief Financial Officer, Executive Vice President
Henry Gosebruch
Executive Vice President, Chief Strategy Officer
Perry Siatis
Executive Vice President, General Counsel, Company Secretary
Address
1 N Waukegan Rd
North Chicago, IL
60064
United States

Top Peers

SYMBOLLASTCHG%CHG
MRK
Merck & Co Inc
106.87-1.72-1.58%
RHHBY
Roche Holding AG
39.38-0.67-1.67%
AZN
AstraZeneca PLC
65.99-0.64-0.96%
NVS
Novartis AG
89.84-2.97-3.20%
PFE
</